Drug repurposing for Chagas disease: In vitro assessment of nimesulide against Trypanosoma cruzi and insights on its mechanisms of action.

por Joana D'Arc S Trindade, Célio Geraldo Freire-de-Lima, Suzana Côrte-Real, Debora Decote-Ricardo, Marco Edilson Freire de Lima
Publicado 2021

Drug repurposing for Chagas disease: In vitro assessment of nimesulide against Trypanosoma cruzi and insights on its mechanisms of action

por Joana D’Arc S. Trindade, Célio Geraldo Freire-de-Lima, Suzana Côrte-Real, Debora Decote-Ricardo, Marco Edilson Freire de Lima
Publicado 2021

X-linked immunodeficient (XID) mice exhibit high susceptibility to Cryptococcus gattii infection

por Israel Diniz-Lima, Pablo Rodrigo da Rosa, Elias Barbosa da Silva-Junior, Joyce Cristina Guimarães-de-Oliveira, Elisangela Oliveira de Freitas, Danielle de Oliveira Nascimento, Alexandre Morrot, Leonardo Nimrichter, Jose Osvaldo Previato, Lucia Mendonça-Previato, Leonardo Freire-de-Lima, Debora Decote-Ricardo, Celio Geraldo Freire-de-Lima
Publicado 2021

Inhibitory effects of Trypanosoma cruzi sialoglycoproteins on CD4+ T cells are associated with increased susceptibility to infection.

por Marise Pinheiro Nunes, Bárbara Fortes, João Luiz Silva-Filho, Eugênia Terra-Granado, Leonardo Santos, Luciana Conde, Isadora de Araújo Oliveira, Leonardo Freire-de-Lima, Marina Vieira Martins, Ana Acacia Sá Pinheiro, Christina Maeda Takyia, Célio Geraldo Freire-de-Lima, Adriane Regina Todeschini, George Alexandre Dosreis, Alexandre Morrot
Publicado 2013